|
Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study Clinical research trials and Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study. Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study clinical trial. Test subjects typically receive the most effective healthcare possible for their Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study  Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
For Condition: HIV Infections
Status: Completed
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: PRIMARY: To identify factors associated with risk of HIV infection through heterosexual activity among urban, inner-city women. SECONDARY: To identify correlates of high-risk behaviors in order to provide a basis for future intervention studies.
Details: At baseline and at 6-month intervals, participants are interviewed about their sexual behavior, drug and alcohol-related behaviors, and recent medical history, and are given a psychosocial assessment. They also undergo a physical exam, including pelvic exam and colposcopy, and have blood and urine specimens collected for HIV testing, drug screening, and STD evaluation. Additionally, participants are given pre- and post-test counseling and education, including information about social services. They are provided with basic gynecological care and either treatment or referral for medical problems.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/49 Years
Genders: Female
Protocol Entry Criteria: Participants must meet the following criteria: - HIV-negative, sexually active women living in social and sexual proximity to men at high risk for acquiring HIV infection. - Able to speak English, Spanish, or Creole. - Living in the geographic area surrounding Kings County Hospital in Brooklyn, New York. (Hospital-based and community-based recruitment sites will be utilized.) Personal history of parenteral drug use by self-report or urine test. Heterosexual contact with men at high risk for HIV infection.
Total Enrollment: 1000
Location and Contact Information:
SUNY / Health Sciences Ctr at Brooklyn
Brooklyn, New York, 11203
United States
Additional Information:
Study ID Numbers: HATS PROSPECTIVE;
Study Start Date:
Record last reviewed: April 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000787
Other Hiv Infections Studies:
1. Metabolism and Body Shape of Healthy Children and Children with Chronic Infections
2. A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success with Itraconazole But Not with Fluconazole
3. Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects with Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
4. A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
5. A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines
Related Studies:
Other HIV Infections Clinical Trials
Other New York Clinical Trials
Other Brooklyn Clinical Trials
Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
|
|
|
|
|
|
|
|
